GlassScriptPhysician profile
Kendra A Boldt
NPI 1700529013
$2,826.04
in general payments reported to CMS, 2019-2025
16 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,500 · 2023: $424 · 2024: $733 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $1,200.00 | 2022 | |
| Kerecis Limited | $295.22 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Stryker Corporation | $224.64 | 2022-2025 | Citrefix, Actishield, Ortholoc 3di |
| Highridge Medical LLC | $165.10 | 2024 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Biomet Ebi Bone Healing System, Ebi Osteogen Implantable Bone Growth Stimulator |
| Horizon Therapeutics Plc | $124.99 | 2023 | Krystexxa |
| Organogenesis INC. | $117.58 | 2023-2024 | Apligraf |
| Becton, Dickinson and Company | $115.44 | 2022 | |
| Checkpoint Surgical, INC | $104.93 | 2023 | Checkpoint Stimulators |
| Nevro Corp. | $100.00 | 2024 | Senza |
| Paratek Pharmaceuticals, INC. | $66.95 | 2024-2025 | Nuzyra |
| Polynovo North America LLC | $66.38 | 2024-2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $64.91 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Amgen INC. | $53.16 | 2025 | Krystexxa |
| Smith+Nephew, INC. | $45.18 | 2025 | Stravix |
| Hydrocision, INC. | $40.95 | 2023 | Tenjet |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $40.61 | 2023 | Phantom Intramedullary Nail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Boldt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.